Spurious drugs worth over Rs 6 crore seized
Spurious drugs worth Rs 6.60 crore was seized by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West Bengal from a whole premises in Kolkata.
Spurious drugs worth Rs 6.60 crore was seized by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West Bengal from a whole premises in Kolkata.
Spurious drugs worth Rs 6.60 crore was seized by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West Bengal from a whole premises in Kolkata.
Indian regulator Central Drugs Standard Control Organisation (CDSCO) has approved Cipla to exclusively distribute and market inhaled insulin in the country, the drugmaker said on Wednesday.
Over 95 per cent regulatory processes currently have been digitized at CDSCO, bringing transparency and increasing trust among stakeholders, said JP Nadda, Union Minister of Health and Family Welfare on Monday.
The announcement follows a comprehensive and in-depth scientific review of India’s vaccine regulatory system by a team of international experts from various countries, led by the WHO.
A team of international experts from various countries, led by WHO (HQ) in Geneva, arrived at this conclusion following a comprehensive and in-depth scientific review of India’s vaccine regulatory system conducted from September 16 to 20.
India, long regarded as the pharmacy of the world, faces yet another challenge as its drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged over 50 widely used drugs as substandard or counterfeit.
RSV is a highly contagious virus that can lead to serious respiratory illness in infants and is also the leading cause of hospitalisation in infants worldwide.
The Central Drugs Standard Control Organisation (CDSCO) has approved AstraZeneca Pharma India's liver cancer drug Tremelimumab Concentrate to be administered intravenously, the company said on Thursday.
Homegrown MedTech solutions provider Xplore Health on Thursday announced that it received approval from the Indian Regulatory Authority CDSCO (Central Drug Standard Control Organization) under the Health Ministry of India for its aspirational medical smartwatch "CardiacSense".
